BMS Data Sharing Request Committee

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001007938	CM214 - Biomarker Analysis From the Phase 3 CheckMate 214 Trial of Nivolumab Plus Ipilimumab (N+I) or Sunitinib (S) in Advanced Renal Cell Carcinoma (aRCC)	Illumina HiSeq 2500 Illumina NovaSeq 6000	213